Sofia Lofvendahl
Overview
Explore the profile of Sofia Lofvendahl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olofsson S, Lofvendahl S, Widen J, Jacobson L, Lindgren P, Stepien K, et al.
JIMD Rep
. 2024 Nov;
65(6):450-460.
PMID: 39512431
Arginase 1 deficiency (ARG1-D) is an ultrarare, metabolic disease which may cause spastic paraplegia, cognitive deficiency, seizures, and ultimately severe disability. The aim of this study was to assess disease...
2.
Andersson E, Lofvendahl S, Olofsson S, Wahlberg K, Bjermer L, Tornling G, et al.
World Allergy Organ J
. 2024 Sep;
17(10):100973.
PMID: 39328212
[This corrects the article DOI: 10.1016/j.waojou.2024.100896.].
3.
Olofsson S, Lofvendahl S, Widen J, Rudebeck M, Lindgren P, Stepien K, et al.
J Med Econ
. 2024 Sep;
27(1):1146-1156.
PMID: 39230682
Background And Aims: Arginase 1 deficiency (ARG1-D) is a ultrarare disease with manifestations that cause mobility and cognitive impairment that progress over time and may lead to early mortality. Diseases...
4.
Norlin J, Lofvendahl S, Schmitt-Egenolf M
Ann Med
. 2024 Aug;
56(1):2386524.
PMID: 39115530
Background: Real-world data on health-related quality of life (HRQoL) in palmoplantar pustulosis (PPP) are scarce and few studies have analysed the generic HRQoL. Objectives: To assess HRQoL using the generic...
5.
Lofvendahl S, Andersson E, Olofsson S, Wahlberg K, Bjermer L, Tornling G, et al.
J Health Econ Outcomes Res
. 2024 Jun;
11(1):157-165.
PMID: 38845782
Timely treatment of acute allergic reactions (AARs) is important to minimize reaction severity. Corticosteroid tablets dissolved in water are commonly used in mainstay treatment. A new oral film that dissolves...
6.
Norlin J, Lofvendahl S, Schmitt-Egenolf M
Ann Med
. 2024 May;
56(1):2341252.
PMID: 38738413
Background: Real-world data on health-related quality of life (HRQoL) in generalized pustular psoriasis (GPP) are scarce and studies have been restricted in terms of instruments used for assessments. Objective: To...
7.
Andersson E, Lofvendahl S, Olofsson S, Wahlberg K, Bjermer L, Tornling G, et al.
World Allergy Organ J
. 2024 Apr;
17(4):100896.
PMID: 38576826
Background: Acute allergic reactions (AARs) occur shortly after exposure to an allergen, and the severity is on a continuum. Systemic corticosteroids (CS) are mainstay treatment of moderate to severe AARs,...
8.
Norlin J, Lofvendahl S, Schmitt-Egenolf M
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068286
Background: Since the introduction of biologics for psoriasis, uptake has been uneven and limited. Few studies have investigated the influence of socioeconomic factors on access to biologics. Objective: To investigate...
9.
Lofvendahl S, Norlin J, Ericson O, Hanno M, Schmitt-Egenolf M
Acta Derm Venereol
. 2023 Sep;
103:adv6497.
PMID: 37707292
The aim of this study was to analyse sick leave in generalized pustular psoriasis, the most severe form of pustular psoriasis. Prolonged sick leave of >14 days was analysed for...
10.
Lofvendahl S, Norlin J, Schmitt-Egenolf M
Br J Dermatol
. 2023 Jun;
189(2):230-232.
PMID: 37285288
No abstract available.